Cancer Family
Neoplasm
CI-CAN-00000001Explore in graph →
Non-malignant22,971 active trials259 approved drugs4,031 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000001Explore in graph →
Clinical trials
105,884 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01163929 | A Study to Look at the Combination of Chemotherapy, Trastuzumab and RAD001 in HER2 Positive Breast Cancer | withdrawn | Phase 2 | 0 | University of KansasOTHER | 0 | Oct 24, 2012 | clinicaltrials |
| NCT01608139 | Study of Curcumin, Vorinostat, and Sorafenib | withdrawn | Phase 1 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Oct 19, 2012 | clinicaltrials |
| Infusion of Expanded Cord Blood T Cells |
| withdrawn |
| Phase 1 |
| 0 |
| M.D. Anderson Cancer CenterOTHER |
| 0 |
| Oct 11, 2012 |
| clinicaltrials |
| NCT00006090 | Arsenic Trioxide in Treating Patients With Refractory or Relapsed Chronic Lymphocytic Leukemia | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Oct 10, 2012 | clinicaltrials |
| NCT00093548 | Vaccine Therapy in Treating Patients With Stage II, Stage IIIA, Stage IIIB, or Stage IVA Liver Cancer | withdrawn | Phase 1 / Phase 2 | 0 | Jonsson Comprehensive Cancer CenterOTHER | 0 | Oct 4, 2012 | clinicaltrials |
| NCT00098462 | Gefitinib and Sirolimus in Treating Patients With Recurrent or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer | withdrawn | Phase 1 / Phase 2 | 0 | Jonsson Comprehensive Cancer CenterOTHER | 0 | Oct 4, 2012 | clinicaltrials |
| NCT00460200 | Depression and Interleukin-6 Production in Patients With Ovarian Epithelial Cancer | withdrawn | — | 0 | Jonsson Comprehensive Cancer CenterOTHER | 0 | Oct 4, 2012 | clinicaltrials |
| NCT00738335 | Stereotactic Radiosurgery and Erlotinib in Treating Patients With Non-Small Cell Lung Cancer and Brain Metastases | withdrawn | Phase 1 | 0 | University of California, San FranciscoOTHER | 1 | Oct 4, 2012 | clinicaltrials |
| NCT00301912 | Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer | withdrawn | Phase 2 | 0 | University of California, San FranciscoOTHER | 1 | Oct 2, 2012 | clinicaltrials |
| NCT00005614 | Management of Metastatic Breast Cancer in Frail Patients | withdrawn | Phase 2 | 0 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 0 | Sep 25, 2012 | clinicaltrials |
| NCT00229801 | Evaluation of Kidney Function in Children With Brain Tumors | withdrawn | N/A | 0 | Children's Healthcare of AtlantaOTHER | 1 | Sep 24, 2012 | clinicaltrials |
| NCT00027521 | Electroporation Therapy With Bleomycin in Treating Patients With Pancreatic Cancer | withdrawn | Phase 1 | 0 | Ichor Medical Systems IncorporatedINDUSTRY | 0 | Sep 19, 2012 | clinicaltrials |
| NCT00293436 | Celecoxib and Erlotinib in Treating Patients With Liver Cancer | withdrawn | Phase 1 / Phase 2 | 0 | University of California, San FranciscoOTHER | 1 | Sep 17, 2012 | clinicaltrials |
| NCT01663415 | A Study to Evaluate the Safety and Efficacy of Enzalutamide in Chemotherapy-Naïve, Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer | withdrawn | Phase 2 | 0 | Astellas Pharma Global Development, Inc.INDUSTRY | 0 | Sep 17, 2012 | clinicaltrials |
| NCT00025532 | Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer | withdrawn | Phase 1 | 0 | University of California, San FranciscoOTHER | 1 | Sep 14, 2012 | clinicaltrials |
| NCT00928161 | Reflux Disease in Head and Neck Cancer Patients Undergoing Radiation Therapy | withdrawn | N/A | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Sep 7, 2012 | clinicaltrials |
| NCT00951470 | Complete Decongestive Therapy (CDT) for Treatment of Head and Neck Lymphedema | withdrawn | N/A | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Sep 7, 2012 | clinicaltrials |
| NCT00969085 | Trial of Curcumin in Cutaneous T-cell Lymphoma Patients | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Sep 7, 2012 | clinicaltrials |
| NCT01269203 | Efficacy of NF-kB Inhibition for Reducing Symptoms During Maintenance Therapy in Multiple Myeloma Patients | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Sep 7, 2012 | clinicaltrials |
| NCT01659047 | A Phase 2, Single-Arm, Open-Label Study Evaluating the Efficacy and Safety of Single Agent GS 1101 (CAL 101) as Therapy for Previously Treated Chronic Lymphocytic Leukemia | withdrawn | Phase 2 | 0 | Gilead SciencesINDUSTRY | 0 | Sep 7, 2012 | clinicaltrials |
| NCT00520325 | A Study of Safety, Tolerability, and Pk of rhMBL in Pediatric Hematology/Oncology Pts With Fever and Neutropenia | withdrawn | Phase 1 | 0 | Enzon Pharmaceuticals, Inc.INDUSTRY | 0 | Sep 5, 2012 | clinicaltrials |
| NCT01521299 | A Dose Escalation Study of Hydroxyurea in Combination With SCH900776 in Advanced Malignant Solid Tumors | withdrawn | Phase 1 | 0 | Dartmouth-Hitchcock Medical CenterOTHER | 0 | Aug 28, 2012 | clinicaltrials |
| NCT00838968 | The Efficiency of Postoperative Interferon-alpha Treatment in p48 Positive Patients With Hepatocellular Carcinoma | withdrawn | N/A | 0 | Fudan UniversityOTHER | 0 | Aug 23, 2012 | clinicaltrials |
| NCT01416961 | Integration of Neutron Therapy in the Treatment Plan for Stage III Non-Small Cell Lung Cancer (NSCLC) | withdrawn | Phase 1 | 0 | Barbara Ann Karmanos Cancer InstituteOTHER | 0 | Aug 22, 2012 | clinicaltrials |
| NCT01661868 | Olaparib for Patients With Recurrent BRCA Deficient Ovarian Cancer | withdrawn | Phase 2 | 0 | Dana-Farber Cancer InstituteOTHER | 1 | Aug 21, 2012 | clinicaltrials |
| NCT00713687 | Gemcitabine/Oxaliplatin and Photodynamic Therapy in Cholangiocarcinoma(GemOx-PDT) | withdrawn | Phase 2 | 0 | Technical University of MunichOTHER | 1 | Aug 10, 2012 | clinicaltrials |
| NCT00386555 | A Phase 2 Study in Patients With Advanced Non-Small Cell Lung Cancer Using New Agents With and Without Docetaxel. | withdrawn | Phase 2 | 0 | Arog Pharmaceuticals, Inc.INDUSTRY | 0 | Aug 9, 2012 | clinicaltrials |
| NCT00962715 | Reactogenicity, Immunogenicity of Trivalent Influenza Vaccine With Recombinant Interferon Alpha Among Chronic Lymphocytic Leukemia | withdrawn | Phase 1 / Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Aug 3, 2012 | clinicaltrials |
| NCT01168882 | Safety and Tolerability of RGB-286638 in Patients With Selected, Relapsed or Refractory Hematological Malignancies | withdrawn | Phase 1 | 0 | AgennixINDUSTRY | 0 | Aug 2, 2012 | clinicaltrials |
| NCT01270893 | Tasigna Neoadjuvant Gastrointestinal Stromal Tumor (GIST) | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Aug 2, 2012 | clinicaltrials |
| NCT00038038 | Assessment of Head and Neck Tumor Hypoxia Using 18F-Fluoromisonidazole | withdrawn | N/A | 0 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 1, 2012 | clinicaltrials |
| NCT00508339 | Functional Outcomes Following Limb Sparing Surgery for Sarcoma Patients | withdrawn | — | 0 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 1, 2012 | clinicaltrials |
| NCT00800566 | Oral Clofarabine in Chronic Lymphocytic Leukemia (CLL) | withdrawn | Phase 1 | 0 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 1, 2012 | clinicaltrials |
| NCT00048087 | Iressa/Docetaxel in Non-Small-Cell Lung Cancer | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 31, 2012 | clinicaltrials |
| NCT00939172 | TTP607 in Refractory Solid Malignancies | withdrawn | Phase 1 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Jul 31, 2012 | clinicaltrials |
| NCT01070186 | Study of Sunitinib in Subjects With High Risk Renal Cell Carcinoma | withdrawn | Phase 2 | 0 | Jonsson Comprehensive Cancer CenterOTHER | 0 | Jul 31, 2012 | clinicaltrials |
| NCT01081106 | Low Level Laser Therapy for Hair Preservation With Chemotherapy for Breast Cancer | withdrawn | N/A | 0 | Northwestern UniversityOTHER | 0 | Jul 31, 2012 | clinicaltrials |
| NCT01159236 | Molecular Triaging of Newly Diagnosed Breast Cancer | withdrawn | N/A | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Jul 31, 2012 | clinicaltrials |
| NCT00434031 | CETRA: Neoadjuvant Caelyx and Trastuzumab in Her-2 Positive Breast Cancer(CETRA) | withdrawn | Phase 2 | 0 | National Cancer Institute, NaplesOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00632437 | Intraoperative Optical Imaging of Brain Function | withdrawn | — | 0 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00811031 | Preoperative Docetaxel for Localized Progressive Castration-resistant Prostate Cancer (CRPC) | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Jul 30, 2012 | clinicaltrials |
| NCT00877617 | Quality of Life in Men With High Risk Localized Prostate Cancer | withdrawn | — | 0 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00960726 | NOV-002 in Myelodysplastic Syndrome (MDS) | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Jul 30, 2012 | clinicaltrials |
| NCT00605709 | Dose-Ranging Safety and Efficacy Study of Topical Creams Containing API 31510 for the Treatment of in Situ Cutaneous Squamous Cell Carcinoma | withdrawn | Phase 2 | 0 | BPGbioINDUSTRY | 0 | Jul 25, 2012 | clinicaltrials |
| NCT01139359 | Safety Study of Darinaparsin in Combination With Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) to Treat Lymphoma | withdrawn | Phase 1 | 0 | Alaunos TherapeuticsINDUSTRY | 0 | Jul 19, 2012 | clinicaltrials |
| NCT01005641 | ELBA: Exemestane and Lapatinib in Advanced Breast Cancer(ELBA) | withdrawn | Phase 2 | 0 | National Cancer Institute, NaplesOTHER | 1 | Jul 13, 2012 | clinicaltrials |
| NCT01296659 | Study of Oral Ridaforolimus in Combination With Standard Chemotherapy for Soft Tissue Sarcoma | withdrawn | Phase 1 | 0 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Jul 12, 2012 | clinicaltrials |
| NCT00003979 | CHS 828 in Treating Patients With Solid Tumors | withdrawn | Phase 1 | 0 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Jul 11, 2012 | clinicaltrials |
| NCT00003985 | KRN7000 in Treating Patients With Solid Tumors | withdrawn | Phase 1 | 0 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Jul 11, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Oct 24, 2012source: clinicaltrials